Applied DNA Sciences : Imperial Capital Comments on Potential for Expanded Use of Botanical DNA in Cotton Industry

To whom it concerns:

Jeffrey Kessler, Imperial Capital's Security (Physical and Monitoring) analyst, published his quarterly 'Security and Alarm Monitoring Industry Update' yesterday in which he dedicated a section to the anti- counterfeiting industry. In the 'Anti-Counterfeiting Industry Update' section, Kessler stated, "Following the DoD's (Department of Defense) logistics division lead on DNA marking of critical electronic components for the military, the cotton industry has begun expanding its use of botanical DNA."

Kessler goes on to cite a recent decision to mark 10 million pounds of Alcala cotton - the highest quality type of Upland cotton - as evidence of growing market demand that began first with the marking of Pima, the highest-quality cotton. He lists several catalysts he believes has caused the cotton industry to begin genotyping and marking cotton with botanical DNA.

To request Kessler's quarterly update in full, please contact your Imperial Capital salesperson. Applied DNA will report its FQ3'16 earnings on Thursday, August 11 after the close of the market. Thank you.

We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual

property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft

and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large- scale production of specific DNA sequences using the polymerase chain reaction.

Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.

Forward-Looking Statements; Third-Party Report

This communication and the report by Imperial Capital referred to herein may be deemed to contain "forward-looking" statements within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe, among other things, patterns and growth trends in the anti-counterfeiting and security industries, and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results and industry trends could differ materially from those discussed in such forward-looking statements due to, among other reasons,

general economic and business conditions, market and industry trends and activity, APDN's short operating history, limited financial resources and limited market acceptance, market competition and various other factors detailed

from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14,

2015, and our subsequent quarterly reports on Form 10-Q filed on February 10, 2016 and May 12, 2016, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law. The opinions and statements contained in the report by Imperial Capital are those of the author and not of APDN. APDN does not warrant or assume any responsibility for the accuracy, completeness, or usefulness of any information, assumption, data, forecast, estimate or projection contained in such report.

Sanjay Hurry, LHA, 212-838-3777, shurry@lhai.com web: www.adnas.com